These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 25703594)
21. Multisystem presentation of Late Onset Pompe Disease: what every consulting neurologist should know. Jastrzębska A; Kostera-Pruszczyk A Neurol Neurochir Pol; 2023; 57(2):143-150. PubMed ID: 36478346 [TBL] [Abstract][Full Text] [Related]
22. Selective screening of late-onset Pompe disease (LOPD) in patients with non-diagnostic muscle biopsies. Meznaric M; Fumic K; Leonardis L J Clin Pathol; 2019 Jul; 72(7):468-472. PubMed ID: 30878973 [TBL] [Abstract][Full Text] [Related]
23. Potential patient screening for late-onset Pompe disease in suspected sleep apnea: a rationale and study design for a Prospective Multicenter Observational Cohort Study in Japan (PSSAP-J Study). Yamauchi M; Nakayama H; Shiota S; Ohshima Y; Terada J; Nishijima T; Kosuga M; Kitamura T; Tachibana N; Oguri T; Shirahama R; Aoki Y; Ishigaki K; Sugie K; Yagi T; Muraki H; Fujita Y; Takatani T; Muro S Sleep Breath; 2021 Jun; 25(2):695-704. PubMed ID: 32808237 [TBL] [Abstract][Full Text] [Related]
24. Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing. Lévesque S; Auray-Blais C; Gravel E; Boutin M; Dempsey-Nunez L; Jacques PE; Chenier S; Larue S; Rioux MF; Al-Hertani W; Nadeau A; Mathieu J; Maranda B; Désilets V; Waters PJ; Keutzer J; Austin S; Kishnani P Orphanet J Rare Dis; 2016 Jan; 11():8. PubMed ID: 26809617 [TBL] [Abstract][Full Text] [Related]
25. Late-Onset Pompe Disease Presenting with Isolated Tongue Involvement. Al-Hashel J; Ismail I Case Rep Neurol; 2022; 14(1):98-103. PubMed ID: 35431876 [TBL] [Abstract][Full Text] [Related]
27. Diagnosis of Pompe disease: muscle biopsy vs blood-based assays. Vissing J; Lukacs Z; Straub V JAMA Neurol; 2013 Jul; 70(7):923-7. PubMed ID: 23649721 [TBL] [Abstract][Full Text] [Related]
28. Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. Koeberl DD; Austin S; Case LE; Smith EC; Buckley AF; Young SP; Bali D; Kishnani PS FASEB J; 2014 May; 28(5):2171-6. PubMed ID: 24443373 [TBL] [Abstract][Full Text] [Related]
29. The new era of Pompe disease: advances in the detection, understanding of the phenotypic spectrum, pathophysiology, and management. Kishnani PS; Beckemeyer AA; Mendelsohn NJ Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):1-7. PubMed ID: 22253049 [TBL] [Abstract][Full Text] [Related]
30. [Myopathy associated with respiratory insufficiency: diagnostic difficulties in adult-onset Pompe disease]. Merkli H; Pál E; Nagy F; Horváth R; Várdi VK; Komoly S; Illés Z Orv Hetil; 2006 Jul; 147(30):1421-4. PubMed ID: 16977780 [TBL] [Abstract][Full Text] [Related]
31. Screening for late-onset Pompe disease in Finland. Palmio J; Auranen M; Kiuru-Enari S; Löfberg M; Bodamer O; Udd B Neuromuscul Disord; 2014 Nov; 24(11):982-5. PubMed ID: 25047669 [TBL] [Abstract][Full Text] [Related]
32. Pompe disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients. Bernstein DL; Bialer MG; Mehta L; Desnick RJ Mol Genet Metab; 2010; 101(2-3):130-3. PubMed ID: 20638881 [TBL] [Abstract][Full Text] [Related]
33. Quantitative computed tomography for enzyme replacement therapy in Pompe disease. Yonee C; Toyoshima M; Young SP; Maruyama S; Higuchi I; Narita A; Maegaki Y; Nanba E; Ohno K; Kawano Y Brain Dev; 2012 Nov; 34(10):834-9. PubMed ID: 22521436 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic criteria for late-onset (childhood and adult) Pompe disease. American Association of Neuromuscular & Electrodiagnostic Medicine Muscle Nerve; 2009 Jul; 40(1):149-60. PubMed ID: 19533647 [TBL] [Abstract][Full Text] [Related]
37. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Hagemans ML; Winkel LP; Van Doorn PA; Hop WJ; Loonen MC; Reuser AJ; Van der Ploeg AT Brain; 2005 Mar; 128(Pt 3):671-7. PubMed ID: 15659425 [TBL] [Abstract][Full Text] [Related]
38. Should patients with asymptomatic pompe disease be treated? A nationwide study in France. Echaniz-Laguna A; Carlier RY; Laloui K; Carlier P; Salort-Campana E; Pouget J; Laforet P Muscle Nerve; 2015 Jun; 51(6):884-9. PubMed ID: 25786784 [TBL] [Abstract][Full Text] [Related]
39. 24-months results in two adults with Pompe disease on enzyme replacement therapy. Vielhaber S; Brejova A; Debska-Vielhaber G; Kaufmann J; Feistner H; Schoenfeld MA; Awiszus F Clin Neurol Neurosurg; 2011 Jun; 113(5):350-7. PubMed ID: 21477922 [TBL] [Abstract][Full Text] [Related]
40. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Müller-Felber W; Horvath R; Gempel K; Podskarbi T; Shin Y; Pongratz D; Walter MC; Baethmann M; Schlotter-Weigel B; Lochmüller H; Schoser B Neuromuscul Disord; 2007 Oct; 17(9-10):698-706. PubMed ID: 17643989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]